BlackRock Amends INSMED Stake: Passive Investment Update
Ticker: INSM · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1104506
| Field | Detail |
|---|---|
| Company | Insmed Inc (INSM) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, amendment, pharmaceuticals
TL;DR
**BlackRock updated its passive stake in INSMED; keep an eye on institutional sentiment.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating a change in its ownership of INSMED Inc. common stock as of December 31, 2023. This amendment, number 11, shows BlackRock's updated passive investment stake in the pharmaceutical company. For investors, this matters because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in market sentiment or investment strategy towards INSMED Inc.
Why It Matters
This filing shows a major institutional investor's updated position in INSMED, which can influence market perception and potentially stock price due to the sheer size of BlackRock's investments.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued passive interest in INSMED Inc. as a sign of ongoing institutional confidence, but this filing alone doesn't warrant immediate action. It's a data point to consider alongside other fundamental and technical analysis.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- INSMED Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the date the SC 13G/A amendment was filed
Forward-Looking Statements
- BlackRock will continue to hold a significant, passive stake in INSMED Inc. (BlackRock Inc.) — high confidence, target: Q2 2024
FAQ
What type of filing is this and what does it generally indicate?
This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It generally indicates that a passive institutional investor, like BlackRock Inc., has updated its ownership stake in a company, in this case, INSMED Inc., and that their intent is not to influence or control the company.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., a major asset management firm with its business address at 50 Hudson Yards, New York, NY.
Which company's securities are being reported on?
The securities being reported on belong to INSMED Inc., a pharmaceutical preparations company located at 700 US Highway 202/206, Bridgewater, NJ.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, meaning the reported ownership figures are accurate as of that date.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of INSMED Inc. mentioned in this filing is 457669307.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding INSMED Inc (INSM).